Stocks  /  NASDAQ  /  Generate Biomedicines Inc.

Generate Biomedicines Inc.

Industry:   Health Care – Biotechnology: Pharmaceutical Preparations

Stock Symbol:   GENB – NASDAQ

 

Animal Usage:   Animal Testing

Our Opinion

Generate Biomedicines Inc. is on the Cruelty Free Investing list for exploiting animals because the company does animal testing to assess a product’s safety profile.

Supporting Evidence:

The company stated in the following report that they exploit animals for drug testing.

“In preclinical mouse and non-human primate (“NHP”) studies, GB-4362 demonstrated dose-dependent reductions in systemic free MMAE exposure.” (Page 7) Read the full document

Company Description

Generate Biomedicines, Inc., engaged in the field of generative biology by using machine learning for drug discovery and development through the programming of novel protein therapeutics in the United States. It uses protein-based modalities for drug development. Generate Biomedicines, Inc. was formerly known as Generate Biologics, Inc. and changed its name to Generate Biomedicines, Inc. in February 2020. The company was incorporated in 2018 and is based in Somerville, Massachusetts.

Company Website: https://generatebiomedicines.com

Contact:  info@generatebiomedicines.com
Scroll to Top